Army's Pan-Coronavirus Vaccine Shows Promise in Early Trials The Army and Walter Reed Army Institute of Research are getting positive early results on the Spike Ferritin Nanoparticle COVID-19 vaccine. The "pan-coronavirus vaccine" performed well with nonhuman primates, and the first phase of human trials will end soon. The trials have been reported to show a potent immune response and wide-ranging protection against SARS-CoV-2 variants, as well as other types of coronaviruses. Read more.
|
|